Epilepsy and ADHD: A Complex Neurological Link

Epilepsy and ADHD overlap far more often than chance would predict. Roughly a quarter of children with epilepsy also meet criteria for ADHD, and children with ADHD develop epilepsy at several times the expected rate. The relationship runs in both directions and appears rooted in shared genetics, overlapping brain-network disruptions, and common neurochemical imbalances rather than one condition simply causing the other. Understanding this link matters because it changes how both conditions are diagnosed, which medications are chosen, and how families plan for the long term.

How Often the Two Conditions Co-Occur

In the general pediatric population, ADHD affects somewhere around 5 to 7 percent of children. Among children with newly diagnosed epilepsy, the rate is dramatically higher. One study of new-onset pediatric epilepsy found ADHD in about 31 percent of cases, compared with 6 percent of healthy controls.¹ A separate analysis reported a prevalence of roughly 25 percent in children with epilepsy, against about 5 percent in the comparison group.² The spread in these numbers reflects differences in how populations were sampled and how strictly ADHD was defined, but the pattern is consistent: children with epilepsy are at least four to five times more likely to have ADHD than their peers.

One detail that catches clinicians off guard is that, in many children, ADHD symptoms are already present before the first seizure. The new-onset epilepsy study noted that ADHD onset preceded the epilepsy diagnosis in the majority of cases.¹ This undermines the old assumption that seizures or anti-seizure medications are what cause attention problems. Something deeper appears to be going on.

The Relationship Goes Both Ways

A large population-based cohort study tracked children with epilepsy and a matched comparison group over a median of about seven years. Children with epilepsy developed ADHD at roughly 2.5 times the rate of those without, after adjusting for age, sex, and where they lived. But the reverse was also true: children diagnosed with ADHD went on to develop epilepsy at nearly four times the expected rate.³ That bidirectional pattern is a strong clue that the two conditions share underlying biology rather than one being a downstream consequence of the other. A review in the International Journal of Molecular Sciences reached the same conclusion, stating that shared genetic and non-genetic factors largely rule out the possibility that this overlap is coincidental.⁴

An interesting wrinkle from the cohort data: the risk of developing ADHD after an epilepsy diagnosis actually increased with age at diagnosis. Children diagnosed with epilepsy between ages 12 and 18 had a much steeper relative risk compared with those diagnosed before age six.³ The reasons for this are not fully understood, but it may reflect the fact that attention demands climb during adolescence, making ADHD symptoms harder to compensate for as schoolwork and social complexity increase.

Shared Genetics

Genome-wide studies have begun to map the genetic overlap between epilepsy and psychiatric conditions, including ADHD. A comprehensive genetic analysis found a statistically significant genetic correlation between the two, and identified several pleiotropic genes that appear to raise risk for both. Among the candidate genes highlighted were SCN1A, which codes for a sodium channel critical to how neurons fire, and VRK2, which has been linked to multiple psychiatric conditions.⁵ A separate study focusing on generalized genetic epilepsy identified two specific genomic loci shared between that form of epilepsy and ADHD.⁶

These numbers are modest. A genetic correlation of about 0.25 means the overlap is real but far from complete; most genetic risk for epilepsy is not also risk for ADHD, and vice versa. But even a partial shared genetic architecture helps explain why the two conditions travel together so often. It also opens the door to future research on whether specific genetic profiles predict which children with epilepsy are most vulnerable to attention problems.

What Is Happening in the Brain

At the level of brain chemistry, one theme keeps surfacing: disrupted balance between excitatory and inhibitory signaling. In a healthy brain, glutamate (the main excitatory chemical) and GABA (the main inhibitory one) exist in a tightly regulated equilibrium. Seizures happen when excitation overwhelms inhibition. Emerging evidence suggests that ADHD also involves a disturbance in this balance, with particular emphasis on abnormal GABA signaling and the interneurons that depend on it. Recent genome-wide association studies have even identified mutations in GABA-related genes in populations with ADHD.⁷ This overlap in neurochemistry gives the two conditions a plausible shared mechanism at the cellular level.

Neuroimaging research adds a structural dimension. In children with epilepsy, reductions in cortical gray matter and disruptions of brain networks have been linked to poorer cognitive performance, and the specific network most affected is the same fronto-striatal-cerebellar circuit that is a hallmark of ADHD.⁸ Work on benign epilepsy with centrotemporal spikes, one of the most common childhood epilepsy syndromes, has shown that children with this form of epilepsy who also have ADHD display disrupted functional connectivity and altered cortical thickness in frontal and other brain regions important for selective attention and impulse control.⁹

Inflammation as a Possible Contributor

There is growing interest in whether chronic low-grade inflammation plays a role in connecting the two conditions. In a study of 50 children with epilepsy, those who also had ADHD had significantly higher blood levels of the inflammatory markers IL-6 and TNF-α compared to those without ADHD. The ADHD group also tended to have an earlier age of seizure onset and a longer duration of epilepsy. Scores on a behavioral rating scale correlated positively with both the duration of epilepsy and the levels of these inflammatory markers.¹⁰ This is still early-stage research, and a single study of 50 children cannot establish causation. But it aligns with a broader body of work suggesting that neuroinflammation contributes to both seizure susceptibility and behavioral disturbances, and it raises the question of whether anti-inflammatory strategies might eventually have a role in managing comorbid ADHD in epilepsy.

The Subclinical EEG Problem

One of the less intuitive aspects of the epilepsy-ADHD connection involves electrical brain activity that does not produce visible seizures. Between seizures, many children with epilepsy continue to have brief bursts of abnormal electrical activity on EEG, known as interictal epileptiform discharges. These bursts are too short to cause a recognizable seizure, but research suggests they can still impair cognition, particularly sustained attention.¹¹ In children with benign epilepsy with centrotemporal spikes, for example, right-sided interictal discharges during sleep appear to interfere with the brain’s ability to maintain focus on waking tasks the next day.

The relevance for ADHD is that some children diagnosed with attention problems may actually be experiencing the cognitive fallout from subclinical epileptic activity rather than, or in addition to, “standard” ADHD. Frequent epileptic discharges and EEG abnormalities are seen in children with ADHD, and these subclinical discharges may contribute to neuropsychological dysfunction in both groups.¹² This overlap makes thorough EEG evaluation particularly important in children who present with attention problems alongside any risk factors for epilepsy.

Absence Seizures Versus Inattention

One common source of diagnostic confusion is the similarity between absence seizures and the inattentive presentation of ADHD. Both can look like a child who “zones out.” A child having an absence seizure briefly loses awareness, often staring blankly for a few seconds before snapping back. A child with inattentive ADHD may appear equally disconnected during a classroom task. The difference matters enormously because the treatments are completely different.

Research has found ways to tease these apart clinically. A study comparing children with confirmed absence seizures to children with inattentive-type ADHD found that two specific parental observations, “does not complete homework” and “does not remain on task,” correctly classified 40 out of 43 children. Parents of children with absence seizures rated these sustained-attention behaviors as much less problematic than parents of children with ADHD.¹³ In other words, the inattention in ADHD tends to be persistent and pervasive, affecting homework completion and on-task behavior throughout the day, while absence seizures cause discrete, brief interruptions that do not necessarily affect a child’s ability to follow through on longer tasks once the seizure is over. When a child presents with staring episodes, this distinction can help clinicians decide whether to order an EEG, pursue ADHD evaluation, or both.

Which Subtype of ADHD Predominates

When ADHD co-occurs with epilepsy, the inattentive presentation dominates. The Irish study cited earlier found that among children with epilepsy who had ADHD, the inattentive subtype was most prevalent at about 14 percent of the total epilepsy sample.² The new-onset epilepsy study similarly described the ADHD in their sample as predominantly inattentive.¹ This is worth knowing because hyperactivity and impulsivity, the more visible ADHD symptoms, may be less prominent in these children. A quiet, dreamy child who is struggling in school may be overlooked for ADHD screening, especially if clinicians and teachers associate ADHD primarily with disruptive behavior. In the epilepsy population, the biggest red flag is often declining academic performance rather than restlessness.

The Cognitive Cost of Having Both

Having either epilepsy or ADHD alone affects cognition. Having both together hits harder than either one individually. A systematic review and meta-analysis found that children with both conditions scored worse across every measured cognitive domain compared with children who had only one or the other, with effect sizes indicating moderate impairments. Compared with healthy controls, the gap was even larger.¹⁴ A separate systematic review zeroed in on the specific domains hit hardest: lower verbal and full-scale IQ scores, more frequent errors on attention tasks, and greater reaction-time variability, with perceptual-motor function and executive function taking the biggest toll.¹⁵

On a behavioral level, the comorbid group also shows more trouble with response inhibition, meaning the ability to stop yourself from acting impulsively, along with higher rates of aggressive behavior and greater stress within the family.¹⁶ These findings underscore why identifying ADHD early in children with epilepsy is not just an academic exercise. The cognitive gap can widen over time if attention problems are unaddressed, affecting school performance, self-esteem, and family dynamics.

Quality of Life and Academic Self-Concept

Children who carry both diagnoses also report meaningfully lower quality of life. In one study, quality of life and academic self-concept were significantly poorer in children with epilepsy who also had ADHD or a learning disability compared with those who had epilepsy alone.¹⁷ Another study found that the group with both ADHD and epilepsy had the lowest total quality-of-life scores across all comparison groups, including lower performance IQ scores and higher rates of low socioeconomic status.¹⁸ It is hard to untangle how much of this is driven by the conditions themselves versus the challenges of managing two chronic diagnoses simultaneously, but for families living it, the practical impact is real regardless of the causal pathway.

Are Stimulants Safe When Seizures Are in the Picture?

For decades, many clinicians were reluctant to prescribe stimulants like methylphenidate to children with epilepsy, fearing that these medications might lower the seizure threshold. This concern was reasonable on paper, since stimulants increase brain activity. But the evidence has consistently failed to support the fear. An early trial found that no child had seizures during the study period, with no significant changes in EEG patterns or anti-seizure drug levels.¹⁹ A more recent review confirmed this, noting that large database and registry studies show methylphenidate is safe in children with ADHD and epilepsy, with no significant effect on seizure frequency.²⁰

That said, the evidence base has real limitations. A critical review noted that the studies supporting methylphenidate safety in epilepsy tend to have small sample sizes, inconsistent definitions of seizure type and severity, and typically enroll children who were already seizure-free for some period before starting stimulants.²¹ So while the overall safety signal is reassuring, the case for stimulants is strongest in children whose seizures are already well controlled. For children with active or difficult-to-control epilepsy, the decision requires closer monitoring and a more cautious approach.

Anti-Seizure Medications and Attention

Just as stimulants raise questions about seizure safety, anti-seizure medications raise questions about attention. Some commonly used anti-seizure drugs have well-documented cognitive and behavioral side effects that can mimic or worsen ADHD symptoms. Topiramate and zonisamide, for instance, are associated with cognitive dulling and memory problems. Levetiracetam and perampanel are linked to irritability and aggressiveness.²² For a child who already has ADHD, adding a medication known to impair focus or escalate behavioral problems creates a tricky clinical situation. Choosing the right anti-seizure drug in this population is less about what controls seizures best in isolation and more about what controls seizures without making attention and behavior worse.

Non-Stimulant Options

When stimulants are not suitable or have not worked, atomoxetine is the most studied non-stimulant alternative for children with both epilepsy and ADHD. One prospective study found that atomoxetine had no significant effect on seizure frequency or severity, and no serious adverse events were reported, although the response rate for ADHD symptoms was modest in this stimulant-resistant group.²³ A larger study of 105 children and adolescents found that about a third showed a meaningful treatment response over 12 weeks, with decreased appetite as the most common side effect. In that study, seizure worsening was observed in a small minority of participants, and only one needed to stop the medication because of it.²⁴

Amphetamine-based stimulants and alpha-2 adrenergic agonists (like guanfacine and clonidine) are also used in practice, but the evidence base for these in children with epilepsy is thin. One retrospective comparison found that methylphenidate produced a higher ADHD response rate than amphetamines in children with epilepsy, with a small number of children in both groups experiencing temporary increases in seizure frequency that resolved after stopping the stimulant.²⁵ Alpha-2 agonists remain largely unstudied in the epilepsy population specifically, though they are sometimes chosen when stimulants and atomoxetine are both problematic.

Transitioning to Adult Care

One challenge that receives far too little attention is what happens when children with both epilepsy and ADHD grow into adolescents and young adults. Pediatric neurologists and psychiatrists often manage the two conditions in a coordinated way, but the transition to adult services frequently fractures that coordination. Young people with epilepsy may face gaps in care between pediatric and adult services, an unstructured transition process, and uncertainty due to the complexity of their condition.²⁶ ADHD is sometimes treated as a childhood condition that resolves, even though it persists into adulthood in the majority of cases. For someone with ongoing epilepsy, losing ADHD treatment continuity can mean worsening attention, poorer medication adherence for anti-seizure drugs, and reduced quality of life during a period already marked by major life transitions like leaving home or entering the workforce.

There is no established consensus on the ideal transition model for this dual-diagnosis population. Some centers use structured transition clinics; many do not. The key practical step for families is to begin planning the transition well before it happens, making sure both conditions are addressed in the adult care team and that the young adult understands their own medication regimen, seizure triggers, and signs that attention problems are worsening.

1
Brain. The frequency, complications and aetiology of ADHD in new onset paediatric epilepsy
2
PubMed. Attention deficit hyperactivity disorder (ADHD) in children with epilepsy
3
PLOS ONE. Correlation between Epilepsy and Attention Deficit Hyperactivity Disorder: A Population-Based Cohort Study
4
PubMed Central. Epilepsy and Attention Deficit Hyperactivity Disorder: Connection, Chance, and Challenges
5
PubMed Central. Shared Genetic Basis and Causality Between Epilepsy and Psychiatric Disorders: Evidence From a Comprehensive Genetic Analysis
6
Brain. Identification of novel genomic risk loci shared between common epilepsies and psychiatric disorders
7
PubMed Central. Novel pharmacological targets for GABAergic dysfunction in ADHD
8
PubMed Central. Quantifying the deficit-imaging neurobehavioural impairment in childhood epilepsy
9
PubMed. ADHD and ADHD-related neural networks in benign epilepsy with centrotemporal spikes: A systematic review
10
PubMed. Role of inflammation in childhood epilepsy and ADHD comorbidity
11
PubMed. Attentional ability in children with epilepsy
12
PubMed. Association between epilepsy and attention deficit/hyperactivity disorder – correlation between interictal epileptiform discharges and behavioral disturbances
13
PubMed. Symptom differences in children with absence seizures versus inattention
14
PubMed. Cognitive functioning in children with both epilepsy and ADHD: A systematic review and meta-analysis
15
Epilepsy & Behavior. Neurocognitive outcomes of ADHD as a comorbidity in pediatric epilepsy: a systematic review
16
PubMed. Clinical and neuropsychological characteristics of children with epilepsy and attention-deficit/hyperactivity disorder
17
PubMed. Quality of life, academic self-concept, and mental health in children with epilepsy: The possible role of epilepsy comorbidities
18
Middle East Current Psychiatry. Comparison of cognitive function, socioeconomic level, and the health-related quality of life between epileptic patients with attention deficit hyperactivity disorder and without
19
JAMA Pediatrics. Methylphenidate in Children With Seizures and Attention-Deficit Disorder
20
PubMed Central. Methylphenidate for attention problems in epilepsy patients: Safety and efficacy
21
PubMed Central. Epilepsy, Attention-Deficit/Hyperactivity Disorder and Methylphenidate: Critical Examination of Guiding Evidence
22
PubMed Central. Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies
23
Epilepsy & Behavior. Tolerability of atomoxetine for treatment of pediatric attention-deficit/hyperactivity disorder in the context of epilepsy
24
PubMed Central. Treatment of Children and Adolescents with Epilepsy with Atomoxetine
25
Neuropsychiatric Disease and Treatment. Epilepsy and attention-deficit hyperactivity disorder: links, risks, and challenges
26
Paediatrics & Child Health. Recommendations for transitioning diabetes, epilepsy, and ADHD youth. The TransiDEA Project